Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context

E-ISSN： 1875-5666|6|7|731-738

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.6, Iss.7, 2006-11, pp. : 731-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cooperating Oncogenic Events in Murine Mammary Tumorigenesis: Assessment of ErbB2, Mutant p53, and Mouse Mammary Tumor Virus

By Zelazny E. Li B. Anagnostopoulos A.-M. Coleman A. Perkins A.S.

Experimental and Molecular Pathology, Vol. 70, Iss. 3, 2001-06 ,pp. : 183-193

Elsevier

Access to resources Recommend Favorite

Inflammation and cancer revisited: An hypothesis on the oncogenic potential of the apoptotic tumor cell

By Gregory Christopher D.

Autoimmunity, Vol. 46, Iss. 5, 2013-08 ,pp. : 312-316

Informa Healthcare

Access to resources Recommend Favorite

E2F decoy suppresses E-Selectin expression in murine cardiac allograft arteriopathy

By Suzuki J. Isobe M. Morishita R. Izawa A. Yamazaki S. Okubo Y. Kaneda Y. Sekiguchi M.

Transplantation Proceedings, Vol. 31, Iss. 5, 1999-08 ,pp. : 2018-2019

Elsevier

Access to resources Recommend Favorite

Acquisition of anergic and suppressive activities in transforming growth factor--costimulated CD4 + CD25 − T cells

By Park Hyung-Bae

International Immunology, Vol. 16, Iss. 8, 2004-08 ,pp. : 1203-1213

Oxford University Press

Access to resources Recommend Favorite

Transcriptional repressor E2F-6 regulates apoptosis of hematopoietic stem cells

By Furukawa Y. Nakamura M. Matsuda M.

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1504-1505

Elsevier

Access to resources Recommend Favorite